| IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review |
28 |
| Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment |
28 |
| Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis |
20 |
| Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis |
17 |
| RANKL: A therapeutic target for bone destruction in rheumatoid arthritis |
16 |
| Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study |
14 |
| Safety, pharmacokinetics, and efficacy of E an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis |
13 |
| Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials |
13 |
| Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis |
12 |
| Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: The Yakumo study |
11 |
| Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective |
11 |
| Detection of synovial inflammation in rheumatic diseases using superb microvascular imaging: Comparison with conventional power Doppler imaging |
11 |
| Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients |
9 |
| Evidence-based clinical practice guideline for adult Still's disease |
9 |
| Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy |
9 |
| Serum cystatin C level is associated with locomotive syndrome risk and can be an early predictor in community-living people: The Yakumo study |
9 |
| IgG4-related kidney disease and retroperitoneal fibrosis: An update |
9 |
| The front line of research into immunoglobin G4-related disease-Do autoantibodies cause immunoglobin G4-related disease? |
8 |
| Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-kappa B and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years' treatment for Japanese rheumatoid arthritis patients |
8 |
| Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept |
8 |
| Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis |
8 |
| Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: A meta-analysis |
8 |
| The decrease in phase angle measured by bioelectrical impedance analysis reflects the increased locomotive syndrome risk in community-dwelling people: The Yakumo study |
8 |
| Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study |
7 |
| Clinical practice guideline for Sjogren's syndrome 2017 |
7 |
| Current diagnosis and treatment of polymyositis and dermatomyositis |
7 |
| TNF-alpha potentiates uric acid-induced interleukin-1 beta (IL-1 beta) secretion in human neutrophils |
7 |
| TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review |
7 |
| Comparative effectiveness of oral pharmacologic interventions for knee osteoarthritis: A network meta-analysis |
6 |
| IgG4-related respiratory disease |
6 |
| IgG4-related periaortitis/periarteritis: An under-recognized condition that is potentially life-threatening |
6 |
| Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease |
6 |
| Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study |
6 |
| The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis |
6 |
| KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker |
6 |
| Predictors of locomotive syndrome in community-living people: A prospective five-year longitudinal study |
6 |
| The utility of 25-question Geriatric Locomotive Function Scale for evaluating functional ability and disease activity in Japanese rheumatoid arthritis patients: A cross-sectional study using NinJa database |
6 |
| Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis |
6 |
| Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis |
6 |
| 2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis |
6 |
| Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease |
5 |
| Systemic lupus erythematosus: nothing stale her infinite variety |
5 |
| Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting |
5 |
| The RORt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients |
5 |
| Role of tenascin-C in articular cartilage |
5 |
| Comparison of clinical and laboratory features of patients with and without allergic conditions in IgG4-related disease: A single-center experience in Japan |
5 |
| Serum levels of proinflammatory, anti-inflammatory cytokines, and RANKL/OPG in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome |
5 |
| Inflammation on spinal magnetic resonance imaging is associated with poor bone quality in patients with ankylosing spondylitis |
5 |
| The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behcet's disease |
5 |
| Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis |
5 |
